U.S. Congress: Legislation to End Cannabis Prohibition Nationwide and Allow Expungements Now Sponsored by Lawmakers From 28 States and D.C.

Legislation to deschedule cannabis nationwide, the MORE Act, is now sponsored by lawmakers from 28 different states and the District of Columbia.

The proposal, which would remove marijuana from the Controlled Substances Act and establish a process for clearing past convictions, has attracted broad support nationwide, with 60 total sponsors (13% of the entire House of Representatives).

Sponsors of the bill include lawmakers representing Nevada, Minnesota, New York, California, Tennessee, Kentucky, Michigan, Vermont, Maine, Washington, Texas, Missouri, Florida, Colorado, Georgia, New Jersey, Illinois, Wisconsin, Louisiana, Indiana, Maryland, Massachusetts, Pennsylvania, Connecticut, Ohio, New Mexico, Virginia, and Arizona have signed on, along with Delegate Eleanor Holmes Norton of D.C.

Altogether, the bill now includes backing from well over half of U.S. states, underscoring growing recognition of the failures of prohibition and the need for national reform. As of now, every sponsor is a Democrat, with no Republican lawmakers having endorsed the measure. A separate proposal to respect state cannabis laws, the STATES 2.0 Act, does have bipartisan support, but has considerably less sponsors (four).

The legislation—known as the Marijuana Opportunity Reinvestment and Expungement (MORE) Act—is positioned as both a criminal justice and public health effort. Beyond removing marijuana from federal drug schedules, it would expunge eligible convictions, offering relief to individuals who continue to face lasting consequences from outdated policies. Supporters say the reforms would bring federal law more closely in line with state-level legalization, where marijuana is already permitted in many jurisdictions.

Several states stand out for having multiple lawmakers sponsoring the legislation, underscoring especially strong regional support for ending federal marijuana prohibition. California leads by a wide margin, with more than half a dozen representatives signed on. Texas and Washington also show notable engagement, each contributing several sponsors despite their sharply different political landscapes. Illinois, Pennsylvania, Georgia, Florida, and New York follow closely behind, each with multiple members backing the proposal.

The expanding roster of congressional supporters reflects a political landscape increasingly ready to move past prohibition and adopt a modernized approach to marijuana policy.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

More articles from The Marijuana Herald can be found below.

Study: Psilocybin Treatment May Benefit Those With PTSD

Study: Psilocybin Treatment May Benefit Those With PTSD

Psilocybin Found to Significantly Reduce Depression in Cancer Patients, Meta-Analysis Shows

Psilocybin Found to Significantly Reduce Depression in Cancer Patients, Meta-Analysis Shows

Virginia Lawmaker Files Bill to Legalize Licensed Recreational Cannabis Sales, Increase Possession Limit

Virginia Lawmaker Files Bill to Legalize Licensed Recreational Cannabis Sales, Increase Possession Limit

New Jersey Bill Would Create State-Funded Subsidy to Cut Medical Marijuana Costs for Medicaid Patients

New Jersey Bill Would Create State-Funded Subsidy to Cut Medical Marijuana Costs for Medicaid Patients

Survey Finds 59% of Indiana Voters Support Legalizing Recreational Cannabis, 84% Support Medical

Survey Finds 59% of Indiana Voters Support Legalizing Recreational Cannabis, 84% Support Medical

Seven of Eight Remaining NFL Playoff Teams Come From States Where Recreational Marijuana Is Legal

Seven of Eight Remaining NFL Playoff Teams Come From States Where Recreational Marijuana Is Legal

Washington Bill Would Replace 37% Marijuana Excise Tax With Weight- and Potency-Based Rates

Washington Bill Would Replace 37% Marijuana Excise Tax With Weight- and Potency-Based Rates

Legal Cannabis Sales in U.S. Pass $2.3 Billion in December, $27 Billion in 2025

Legal Cannabis Sales in U.S. Pass $2.3 Billion in December, $27 Billion in 2025

Gelteq Reports Preclinical Results Showing Oral Gel Boosts CBD Absorption

Gelteq Reports Preclinical Results Showing Oral Gel Boosts CBD Absorption

Glass House and University of California Berkeley Secure $1.8 Million State Grant to Study Marijuana Crop Yields

Glass House and University of California Berkeley Secure $1.8 Million State Grant to Study Marijuana Crop Yields

Smart & Safe Florida Raises More Than $52 Million to Support 2026 Marijuana Legalization Initiative

Smart & Safe Florida Raises More Than $52 Million to Support 2026 Marijuana Legalization Initiative

Study: CBD Shown to Reduce Seizures Across Wide Range of Treatment-Resistant Epilepsies

Study: CBD Shown to Reduce Seizures Across Wide Range of Treatment-Resistant Epilepsies

Public Marijuana Possession and Consumption Would be Downgraded to Civil Violation Under New Delaware Bill

Public Marijuana Possession and Consumption Would be Downgraded to Civil Violation Under New Delaware Bill

Washington, D.C. Medical Marijuana Sales Hit $100.9 Million in 2025 as Patient Count Grows to Nearly 100,000

Washington, D.C. Medical Marijuana Sales Hit $100.9 Million in 2025 as Patient Count Grows to Nearly 100,000

Connecticut Sets New Monthly Marijuana Sales Record in December as Prices Hit All-Time Low

Connecticut Sets New Monthly Marijuana Sales Record in December as Prices Hit All-Time Low

Study: CBD Shows Potent Antibacterial Activity Against Drug-Resistant Enterococcus Strains

Study: CBD Shows Potent Antibacterial Activity Against Drug-Resistant Enterococcus Strains

Study: Hemp Seed Extracts May Enhance Effectiveness of Antibiotics and Antifungal Medications

Study: Hemp Seed Extracts May Enhance Effectiveness of Antibiotics and Antifungal Medications

Study: CBD Gel Reduced Jaw Muscle Activity in Adults With Temporomandibular Disorders

Study: CBD Gel Reduced Jaw Muscle Activity in Adults With Temporomandibular Disorders